Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours. Schubert NA, Chen CY, Rodriguez A, Koster J, et al. Eur J Cancer 2022;170:196-208.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schubert NA, Chen CY, Rodriguez A, Koster J, et al. Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours. Eur J Cancer 2022;170:196-208.
PMID: 35671543